We have enrolled the first U.S. patient in the ATHENA clinical trial evaluating the ANA funnel catheter for the treatment of ischemic stroke.
ATHENA is a global, randomized 327-patient pivotal study evaluating the safety and effectiveness of Anaconda’s proprietary ANA Funnel Catheter™. The device is designed for use during stent retriever-based thrombectomy to facilitate clot removal by restricting flow during retrieval, enabling simultaneous aspiration and reducing the risk of clot fragmentation at capture in patients suffering from large vessel occlusion acute ischemic stroke.
